0001346302-21-000060.txt : 20210608 0001346302-21-000060.hdr.sgml : 20210608 20210608190930 ACCESSION NUMBER: 0001346302-21-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210608 FILED AS OF DATE: 20210608 DATE AS OF CHANGE: 20210608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALKUFF DAWN CENTRAL INDEX KEY: 0001743658 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38536 FILM NUMBER: 211003507 MAIL ADDRESS: STREET 1: C/O XERIS PHARMACEUTICALS STREET 2: 180 N. LASALLE ST., STE. 1800 CITY: CHICAGO STATE: IL ZIP: 60601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XERIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001346302 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203352427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 844-445-5704 MAIL ADDRESS: STREET 1: 180 NORTH LASALLE STREET STREET 2: SUITE 1600 CITY: CHICAGO STATE: IL ZIP: 60601 4 1 wf-form4_162319374400964.xml FORM 4 X0306 4 2021-06-08 0 0001346302 XERIS PHARMACEUTICALS INC XERS 0001743658 HALKUFF DAWN C/O XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 1 0 0 0 Stock Option (Right to Buy) 3.9 2021-06-08 4 A 0 11228 0 A 2031-06-08 Common Stock 11228.0 11228 D Such options will vest in full upon the earlier to occur of June 8, 2022 or the date of the Company's next annual meeting of stockholders. /s/ Beth Hecht, as Attorney-in-Fact 2021-06-08